Journal profile · Clinical Neurology
Epileptic Disorders
ISSN 1294-9361 · eISSN 1950-6945 · John Libbey Eurotext · FRANCE · Quarterly · Founded 2010
Epileptic Disorders: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.47; hybrid open access; APC about USD 2,430; median 68 days to acceptance (110 articles, last 24 months); community-reported acceptance: easy; 174 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Epileptic Disorders is published by John Libbey Eurotext and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Epilepsy research and treatment, Pharmacological Effects and Toxicity Studies and Neuroscience and Neuropharmacology Research, together about 52.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
<em>Epileptic Disorders</em> is an educational ILAE journal publishing original research on clinical practice in epileptology, aiming to enhance epilepsy care and research.
From the journal's Aims & Scope
Research area (LetPub): Clinical Neurology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Epilepsy research and treatmentMedicine32.7%
- Pharmacological Effects and Toxicity StudiesMedicine10.9%
- Neuroscience and Neuropharmacology ResearchNeuroscience8.8%
- EEG and Brain-Computer InterfacesNeuroscience5.8%
- Neurological disorders and treatmentsMedicine4.4%
- Neonatal and fetal brain pathologyMedicine3.7%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology3.6%
- Glycogen Storage Diseases and MyoclonusMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Clinical Neurology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.47LetPub ·
- Impact factor (publisher)
- 2.5Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher)
- 3.9Publisher website ·
- SJR 2026-06
- 0.71LetPub ·
- SNIP 2026-06
- 1.26LetPub ·
- h-index
- 48LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 997OpenAlex ·
- 2-year mean citedness
- 1.08OpenAlex ·
- Self-citation rate
- 8%LetPub ·
- Share of gold OA articles
- 38.13%LetPub ·
Volume
- Articles per year
- 100LetPub ·
Articles by year OpenAlex count · 2,741 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 263 | 159 | 46 |
| 2025 | 174 | 98 | 193 |
| 2024 | 146 | 102 | 391 |
| 2023 | 163 | 102 | 933 |
| 2022 | 151 | 138 | 1,363 |
| 2021 | 133 | 116 | 1,230 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
68 daysMedian, submission to acceptance · P25–P75 46 days – 123 days
- Acceptance to online
- median 18 days (110 articles)
- Submission to online
- median 98 days
- Sample
- 110 articles with submission and acceptance dates (461 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 44%Publisher website ·
- Submission to first decision
- 18 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,430 / EUR 2,100 / GBP 1,760 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- John Libbey Eurotext
- Country or region
- FRANCE
- Language
- English
- Frequency
- Quarterly
- Founded
- 2010
- ISSN
- 1294-9361
- Electronic ISSN
- 1950-6945
- Society / sponsor
- International League Against Epilepsy
- Latest issue on the website
- Volume 28, Issue 4 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Epileptic Disorders
What CAS zone is Epileptic Disorders in?
In the 2025 upgraded edition of the CAS Journal Ranking, Epileptic Disorders is in Zone 4 of Medicine, and in Zone 4 of the minor category Clinical Neurology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Epileptic Disorders?
The latest impact factor listed by LetPub is 2.47; CiteScore 3.9, h-index 80.
How long does peer review take at Epileptic Disorders?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 68 days (interquartile range 46–123 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 44%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Epileptic Disorders?
According to LetPub and DOAJ records, Epileptic Disorders is indexed in SCIE and Scopus.
Is Epileptic Disorders open access, and what is the APC?
Epileptic Disorders is a hybrid journal. For open-access publication: APC about USD 2,430.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .